SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Previous Page7891011121314Next Page
2026-05-15GRCESCHEDULE 13G/AADAR1 Capital Management Discloses 9.9% Stake in Grace Therapeutics, Inc.MEDIUM
ADAR1 Capital Management, LLC, along with its affiliates ADAR1 Capital Management GP, LLC and Daniel Schneeberger, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in Grace Therapeutics, Inc. (GRCE). The filing reports a beneficial ownership of 1,717,426 shares of common stock, representing a 9.9% owner...
Nano CapBiotechnologyownership +9.90%
2026-05-15IKTSCHEDULE 13G/AADAR1 Capital Management Reduces Stake in Inhibikase Therapeutics to 8.5%MEDIUM
On May 15, 2026, ADAR1 Capital Management, LLC and its affiliates filed a Schedule 13G/A regarding their holdings in Inhibikase Therapeutics, Inc. (IKT). The filing indicates a decrease in ownership for ADAR1 Capital Management GP, LLC, which now reports beneficial ownership of 11,832,998 shares, representing an 8.5% s...
Micro CapBiotechnologyownership-1.40%
2026-05-15QNRXSCHEDULE 13G/AADAR1 Capital Management Reports 4.9% Stake in Quoin Pharmaceuticals, Ltd. (QNRX)MEDIUM
On May 15, 2026, ADAR1 Capital Management, LLC, alongside ADAR1 Capital Management GP, LLC and Daniel Schneeberger, filed a Schedule 13G/A regarding their holdings in Quoin Pharmaceuticals, Ltd. (QNRX). The reporting persons disclosed beneficial ownership of 102,883 American Depositary Shares (ADS), representing a 4.9%...
Nano Capownership +4.90%
2026-05-15OKURSCHEDULE 13G/AADAR1 Capital Management Discloses 6.0% Stake in OnKure Therapeutics, Inc. (OKUR)MEDIUM
ADAR1 Capital Management, LLC, along with its general partner ADAR1 Capital Management GP, LLC and manager Daniel Schneeberger, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in OnKure Therapeutics, Inc. (OKUR). The filing reports a combined beneficial ownership of 2,434,941 shares of Class A Common S...
Micro CapBiotechnologyownership +5.00%
2026-05-15EQSCHEDULE 13G/AADAR1 Capital Management Increases Stake in Equillium, Inc. to 9.5%HIGH
On May 15, 2026, ADAR1 Capital Management, LLC, alongside ADAR1 Capital Management GP, LLC and Daniel Schneeberger, filed a Schedule 13G/A regarding their holdings in Equillium, Inc. (EQ). The filing reveals that ADAR1 Capital Management GP, LLC beneficially owns 6,306,184 shares of common stock, representing a 9.5% ow...
Micro CapBiotechnologyownership +9.50%
2026-05-15ADILSCHEDULE 13G/AArmistice Capital Reduces Stake in Adial Pharmaceuticals to 4.99%HIGH
On May 15, 2026, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G/A regarding their holdings in Adial Pharmaceuticals, Inc. (ADIL). The filing reveals a significant decrease in their ownership position. As of the event date of March 31, 2026, the reporting persons beneficially own 274,139 shares of common st...
Nano CapBiotechnologyownership-5.00%
2026-05-15AEMDSCHEDULE 13G/AArmistice Capital, LLC Increases Stake in Aethlon Medical, Inc. to 4.99%MEDIUM
On May 15, 2026, Armistice Capital, LLC and Steven Boyd filed an amended Schedule 13G (Amendment No. 1) regarding their holdings in Aethlon Medical, Inc. (AEMD). The filing reports that as of March 31, 2026, the reporting persons beneficially own 82,410 shares of common stock, representing a 4.99% ownership stake in th...
Nano CapMedical Devicesownership +4.99%
Sponsored
2026-05-15AGIOSCHEDULE 13G/AArmistice Capital, LLC Increases Stake in Agios Pharmaceuticals to 4.57%MEDIUM
On May 15, 2026, Armistice Capital, LLC and its managing member Steven Boyd filed a Schedule 13G/A regarding their holdings in Agios Pharmaceuticals, Inc. (AGIO). The filing reveals that the reporting persons beneficially own 2,716,000 shares of common stock, representing a 4.57% ownership stake in the company. This re...
Small CapBiotechnologyownership +4.57%
2026-05-15ADCSCHEDULE 13G/ACohen & Steers, Inc. Reports Significant Increase in Stake of Agree Realty Corp (ADC) to 14.93%HIGH
On May 15, 2026, Cohen & Steers, Inc. filed a Schedule 13G/A indicating a significant increase in its holdings of Agree Realty Corporation (ADC). The filing reports that as of March 31, 2026, Cohen & Steers, Inc. and its subsidiaries beneficially own 17,918,363 shares of common stock, representing a 14.93% ownership st...
Mid CapREIT - Retailownership +14.93%
2026-05-15AIRGSCHEDULE 13G/AJacob Suen Increases Stake in Airgain, Inc. to 6.6% ownershipMEDIUM
On May 15, 2026, Jacob Suen filed an amended Schedule 13G (Amendment No. 1) regarding his holdings in Airgain, Inc. (AIRG). As of the event date of March 31, 2026, Suen reported beneficial ownership of 883,453 shares of Common Stock, representing 6.6% of the company's outstanding shares. This position marks an increase...
Micro CapCommunication Equipmentownership +6.60%
2026-05-15FBRXSCHEDULE 13G/AAlger Associates, Inc. Acquires 10.2% Stake in Forte Biosciences, Inc. (FBRX)HIGH
Alger Associates, Inc. has filed a Schedule 13G/A (Amendment No. 8) regarding its holdings in Forte Biosciences, Inc. (FBRX). As of the event date on March 31, 2026, the filer reported beneficial ownership of 1,272,596 shares of common stock, representing a 10.2% stake in the company. This marks a significant increase ...
Small CapBiotechnologyownership +10.20%
2026-05-15LGMKSCHEDULE 13G/AAlpha Capital Anstalt Reports 0.003% Stake in LogicMark, Inc. via Amendment No. 2
Alpha Capital Anstalt filed a Schedule 13G/A (Amendment No. 2) with the SEC on May 15, 2026, regarding its holdings in LogicMark, Inc. (LGMK). The filing indicates that as of the event date on May 13, 2026, Alpha Capital Anstalt beneficially owns 3,026 shares of LogicMark's common stock. This position represents approx...
Health Information Servicesownership +0.00%
2026-05-15ALXOSCHEDULE 13G/AHBM Healthcare Investments Reports 6.5% Stake in ALX Oncology Holdings Inc. (ALXO)MEDIUM
On May 15, 2026, HBM Healthcare Investments (Cayman) Ltd. filed a Schedule 13G/A regarding its holdings in ALX Oncology Holdings Inc. (ALXO). The filing indicates that as of March 31, 2026, the reporting person beneficially owns 8,590,692 shares of Common Stock, representing approximately 6.5% of the company's outstand...
Micro CapBiotechnologyownership +6.50%
2026-05-15ALXOSCHEDULE 13G/ARedmile Group, LLC Increases Stake in ALX Oncology Holdings Inc. to 6.8%HIGH
Redmile Group, LLC, along with Jeremy C. Green and Redmile Biopharma Investments III, L.P., filed a Schedule 13G/A on May 15, 2026, disclosing a 6.8% stake in ALX Oncology Holdings Inc. (ALXO). As of the event date on March 31, 2026, the reporting persons beneficially owned 9,214,188 shares of common stock. This positi...
Micro CapBiotechnologyownership +6.80%
Sponsored
2026-05-15AEESCHEDULE 13G/AT. Rowe Price Investment Management Increases Stake in Ameren Corp to 2.7%
T. Rowe Price Investment Management, Inc. filed a Schedule 13G/A on May 15, 2026, disclosing an increased ownership stake in Ameren Corporation (AEE). As of the event date on March 31, 2026, the firm reported beneficial ownership of 7,520,678 shares of common stock, representing 2.7% of the company. This reflects an in...
Mega CapUtilities - Regulated Electricownership +2.70%
2026-05-15CRNCSCHEDULE 13G/AAmerican Capital Management Reports 5.6% Passive Stake in Cerence, Inc. (CRNC)MEDIUM
American Capital Management, Inc. has filed a Schedule 13G/A with the SEC, reporting a 5.6% ownership stake in Cerence, Inc. (CRNC). As of the event date on March 31, 2026, the firm beneficially owns 1,385,539 shares of common stock. The filing indicates that American Capital Management holds sole voting power over 2,5...
Small CapSoftware - Applicationownership +5.60%
2026-05-15APEISCHEDULE 13G/ADivisadero Street Capital Management, LP Increases Stake in American Public Education, Inc. to 5.7%MEDIUM
On May 15, 2026, Divisadero Street Capital Management, LP, along with its affiliates, filed a Schedule 13G/A reporting a significant increase in their position in American Public Education, Inc. (APEI). The reporting group, which includes William Zolezzi and Divisadero Street Partners, L.P., now beneficially owns 1,052...
Small CapEducation & Training Servicesownership +5.70%
2026-05-15APEISCHEDULE 13G/ANo Street GP LP Discloses 3.5% Stake in American Public Education Inc (APEI)
No Street GP LP filed a Schedule 13G/A on May 15, 2026, disclosing a new position in American Public Education Inc (APEI). As of the event date on March 31, 2026, the San Francisco-based investment adviser reported beneficial ownership of 647,588 shares of common stock. This represents a 3.5% ownership stake in the com...
Small CapEducation & Training Servicesownership +3.50%
2026-05-15UTZSCHEDULE 13G/AAmeriprise Financial, Inc. Reports 2.2% Stake in Utz Brands, Inc. via Amendment 3
Ameriprise Financial, Inc. (AFI) filed a Schedule 13G/A on May 15, 2026, disclosing its position in Utz Brands, Inc. (UTZ) as of March 31, 2026. The filing indicates that AFI beneficially owns 1,905,537 shares of Class A Common Stock, representing 2.2% of the class. This is an increase from the previously reported 0.0%...
Small CapPackaged Foodsownership +2.20%
2026-05-15TTISCHEDULE 13G/AAmeriprise Financial, Inc. Reports 4.1% Stake in TETRA Technologies, Inc. via Schedule 13G/AMEDIUM
Ameriprise Financial, Inc. (AFI) filed a Schedule 13G/A on May 15, 2026, disclosing a 4.1% ownership stake in TETRA Technologies, Inc. (TTI). As of the event date of March 31, 2026, the reporting person beneficially owns 5,515,522 shares of common stock. This filing represents an increase in reported holdings compared ...
Small CapOil & Gas Equipment & Servicesownership +4.10%
2026-05-15VETSCHEDULE 13G/AAmeriprise Financial, Inc. Increases Stake in Vermilion Energy Inc. to 3.4%MEDIUM
Ameriprise Financial, Inc. (AFI) and its subsidiary, Columbia Management Investment Advisers, LLC (CMIA), filed a Schedule 13G/A on May 15, 2026, regarding their holdings in Vermilion Energy Inc. (VET). The filing indicates that as of March 31, 2026, the reporting entities collectively hold 5,232,096 shares of common s...
Small CapOil & Gas E&Pownership +3.40%
Sponsored
2026-05-15OSPNSCHEDULE 13G/AAmeriprise Financial, Inc. Discloses 0.3% Stake in OneSpan Inc. via Schedule 13G/A
Ameriprise Financial, Inc. (AFI) filed a Schedule 13G/A on May 15, 2026, disclosing a position in OneSpan Inc. (OSPN). As of the event date on March 31, 2026, the reporting person beneficially owns 123,671 shares of Common Stock, representing 0.3% of the class. This filing serves as an amendment to a previous statement...
Small CapSoftware - Infrastructureownership +0.30%
2026-05-15SNCYSCHEDULE 13G/AAmeriprise Financial Reports 0.2% Stake in Sun Country Airlines Holdings, Inc.
Ameriprise Financial, Inc. (AFI) filed a Schedule 13G/A on May 15, 2026, disclosing a position in Sun Country Airlines Holdings, Inc. (SNCY). As of the event date on March 31, 2026, Ameriprise Financial and its subsidiary, Columbia Management Investment Advisers, LLC (CMIA), reported beneficial ownership of 92,082 shar...
Small CapAirlinesownership +0.20%
2026-05-15KTTASCHEDULE 13G/AAmeriprise Financial Reports 5.4% Stake in Pasithea Therapeutics Corp (KTTA) via 13G/A FilingMEDIUM
On May 15, 2026, Ameriprise Financial, Inc. (AFI) filed a Schedule 13G/A with the SEC, reporting a significant increase in its stake in Pasithea Therapeutics Corp (KTTA). As of the event date of March 31, 2026, AFI, along with its subsidiary Columbia Management Investment Advisers, LLC (CMIA), reported beneficial owner...
Nano CapBiotechnologyownership +5.40%
2026-05-15LYFTSCHEDULE 13G/AAmeriprise Financial Reports 9.2% Stake in Lyft, Inc. via Subsidiary Columbia ManagementHIGH
Ameriprise Financial, Inc. (AFI) filed a Schedule 13G/A on May 15, 2026, reporting a significant increase in its position in Lyft, Inc. (LYFT). As of the event date on March 31, 2026, AFI beneficially owns 36,498,425 shares of Class A Common Stock, representing 9.2% of the class. This position is primarily held through...
Mid CapSoftware - Applicationownership +9.20%
Previous Page7891011121314Next Page